| Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites F Rocamora, L Zhu, KY Liong, A Dondorp, O Miotto, S Mok, Z Bozdech PLoS pathogens 14 (3), e1006930, 2018 | 160 | 2018 |
| The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background L Zhu, J Tripathi, FM Rocamora, O Miotto, R van der Pluijm, TS Voss, ... Nature communications 9 (1), 5158, 2018 | 47 | 2018 |
| Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway GM LaMonte, F Rocamora, DS Marapana, NF Gnädig, S Ottilie, MR Luth, ... Nature communications 11 (1), 1780, 2020 | 32 | 2020 |
| Genomic approaches to drug resistance in malaria F Rocamora, EA Winzeler Annual Review of Microbiology 74, 761-786, 2020 | 16 | 2020 |
| PfMFR3: A Multidrug-Resistant Modulator in Plasmodium falciparum F Rocamora, P Gupta, ES Istvan, MR Luth, EF Carpenter, K Kümpornsin, ... ACS Infectious Diseases 7 (4), 811-825, 2021 | 14 | 2021 |
| Tracking Resistance to Artemisinin Collaboration I (2018). The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background L Zhu, J Tripathi, FM Rocamora, O Miotto, R van der Pluijm, TS Voss, ... Nat. Commun 9, 5158, 2018 | 13 | 2018 |
| Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies F Rocamora, AG Peralta, S Shin, J Sorrentino, M Wu, EA Toth, TR Fuerst, ... Biotechnology Advances, 108206, 2023 | 12 | 2023 |
| Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug target ES Istvan, F Guerra, M Abraham, KS Huang, F Rocamora, H Zhao, L Xu, ... Science translational medicine 15 (686), eadc9249, 2023 | 9 | 2023 |
| Development of Potent and Highly Selective Epoxyketone‐Based Plasmodium Proteasome Inhibitors J Almaliti, P Fajtová, J Calla, GM LaMonte, M Feng, F Rocamora, S Ottilie, ... Chemistry–A European Journal 29 (20), e202203958, 2023 | 5 | 2023 |
| Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38 JF Armstrong, B Campo, SPH Alexander, LB Arendse, X Cheng, ... British Journal of Pharmacology 180 (15), 1899-1929, 2023 | 4 | 2023 |
| Semi-synthetic analogues of Cryptolepine as a potential source of sustainable drugs for the treatment of malaria, human African trypanosomiasis, and cancer YZ Abacha, AD Forkuo, SY Gbedema, N Mittal, S Ottilie, F Rocamora, ... Frontiers in Pharmacology 13, 875647, 2022 | 4 | 2022 |
| Antagonistic roles of NOT1 paralogues in the timing of gene expression in Plasmodium falciparum Y Liu, R Rai, L Zhu, C Zhang, F Rocamora, M Featherstone, Z Bozdech bioRxiv, 2020.02. 12.945477, 2020 | 2 | 2020 |
| Pan-active imidazolopiperazine antimalarials target thePlasmodium falciparumintracellular secretory pathway GM LaMonte, DS Marapana, N Gnadig, S Ottilie, MR Luth, TS Worgall, ... | 1 | 2019 |
| Genetic polymorphisms in CYP1A1, GSTM1, GSTP1, GSTT1, NAT1 and NAT2 and oral cavity cancer risk among Filipinos EMC Cutiongco-De La, CA Ngelangel, AY Pontejos, CD Padilla, ... Acta Medica Philippina 47 (4), 2013 | 1 | 2013 |
| Glycoengineered recombinant alpha1-antitrypsin results in comparablein vitroandin vivoactivities to human plasma-derived protein F Rocamora, S Schoffelen, J Arnsdorf, EA Toth, Y Abdul, TE Cleveland, ... | | 2024 |
| Review 3:" Evidence of Artemisinin Partial Resistance in North-Western Tanzania: Clinical and Drug Resistance Markers Study" R Mwaiswelo Rapid Reviews Infectious Diseases, 2024 | | 2024 |
| Antiplasmodial peptaibols act through membrane directed mechanisms JE Collins, JW Lee, F Rocamora, GS Saggu, KL Wendt, CFA Pasaje, ... Cell Chemical Biology 31 (2), 312-325. e9, 2024 | | 2024 |
| Discovery of Potent Antimalarial Type II Kinase Inhibitors with Selectivity over Human Kinases L Wang, MJ Bohmer, J Wang, F Nardella, J Calla, M Laureano De Souza, ... Journal of Medicinal Chemistry 67 (2), 1460-1480, 2024 | | 2024 |
| Glycoengineered recombinant alpha1-antitrypsin results in comparable in vitro and in vivo activities to human plasma-derived protein F Rocamora, S Schoffelen, J Arnsdorf, EA Toth, Y Abdul, TE Cleveland, ... bioRxiv, 2024.03. 27.587088, 2024 | | 2024 |
| The Prevalence of CYP2D6 Gene Polymorphisms among Filipinos and their use as Biomarkers for Lung Cancer Risk EM Cutiongco-de la Paz, CA Ngelangel, A David-Wang, JB Nevado Jr, ... Acta Medica Philippina 51 (3), 2017 | | 2017 |
